MK

Mahesh Krishnat Sutar

Active Director Director DIN 10170334
DIN 10170334 First appointment May 2023 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Mahesh Krishnat Sutar

Data last updated:

Mahesh Krishnat Sutar is a Director at Pulsenova Healthcare Private Limited (since 2023). The company operates in Chemicals.

DIN 10170334
Primary Designation Director
Industry Chemicals
First Appointment 19 May 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pulsenova Healthcare Private Limited U24230PN2023PTC217639
Director19 May 20232023Active

Directorship timeline

Open interactive timeline →
Pulsenova Healthcare Private Limited
Premium access

Shareholding and investment profile for Mahesh Krishnat Sutar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mahesh Krishnat Sutar

Mahesh Krishnat Sutar currently holds 1 directorship: Pulsenova Healthcare Private Limited (Director, since 19 May 2023).

Mahesh Krishnat Sutar was first appointed on 19 May 2023 as Director at Pulsenova Healthcare Private Limited.

The current boards of Mahesh Krishnat Sutar's companies include Rajnandini Sambhajirao Shinde (Pulsenova Healthcare Private Limited), Sambhajirao Narayanrao Shinde (Pulsenova Healthcare Private Limited), Sandip Gulabrav Jadhav (Pulsenova Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available